News
What's new in heart failure management
iHF offers a wealth of constantly updated information on heart failure drugs and device solutions to improve patient care.
-
-
-
-
Myocardial dysfunction & atrial disorders
What is the role of mechanical circulatory support in decompensated heart failure?
-
-
Myocardial dysfunction & atrial disorders
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
-
-
Myocardial dysfunction & atrial disorders
Chronic heart failure: in which clinical scenarios interventions can play a role?
-
Myocardial dysfunction & atrial disorders
Standardized home-based titration: a new paradigm in Heart Failure management
-
Myocardial dysfunction & atrial disorders
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
-
Myocardial dysfunction & atrial disorders
Systemic Right Ventricular Heart Failure: Functional and Quality-of-Life Benefits with Dapagliflozin
-
Myocardial dysfunction & atrial disorders
Why does combining oral therapy and devices matter in managing refractory heart failure?
-
Myocardial dysfunction & atrial disorders
Another failure for spironolactone in cardiovascular prevention among dialysis patients
-
-
Myocardial dysfunction & atrial disorders
Real-world data on sudden cardiac arrest and WCD therapies in high-risk patients
-
Myocardial dysfunction & atrial disorders
Heart failure with improved ejection fraction: finerenone effective in reducing cardiovascular risk
-
Myocardial dysfunction & atrial disorders
Guideline-Directed Medical Therapy and Left Ventricular Ejection Fraction: from static measure to trajectories of change
-
-
-
-
-
-
Myocardial dysfunction & atrial disorders
In heart failure, echocardiographic parameters of right ventricular function are powerful tools to predict renal failure
-
-
Editorial
Editorial from Izabella Uchmanowicz
-
Editorial
Editorial from Emanuele Barbato
-
Interview
An interview with Giuseppe Rosano
-
Interview
An interview with Emanuele Barbato
